A window-of-opportunity biomarker study of etodolac in resectable breast cancer.
Schwab RB, Kato S, Crain B, Pu M, Messer K, Weidner N, Blair SL, Wallace AM, Carson DA, Parker BA.
Schwab RB, et al. Among authors: kato s.
Cancer Med. 2015 Oct;4(10):1583-8. doi: 10.1002/cam4.512. Epub 2015 Aug 15.
Cancer Med. 2015.
PMID: 26275572
Free PMC article.
Clinical Trial.